Some people lose weight with no nausea at all, and severe, persistent nausea should be discussed with your doctor
Tapering the Dose: Gradually reducing the dose rather than stopping abruptly to help the body adjust
While semaglutide targets a single receptor and tirzepatide targets two, retatrutide is a triple agonist simultaneously activating GLP-1, GIP, and glucagon receptors
Best for Nocatee residents with 50+ pounds to lose or complex health situations
Diabetes Obes Metab 2019;21:10371042 Bezin J, Gouverneur A, Pnichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL
Upon analysis, researchers found there were about 1 million new users of GLP-1 medications between 2011 and 2023